CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 


CancerNetwork.
 

Novel Targets, Enhanced Donor Transplantation, Show Promise in Blood Cancers

By Samuel Silver, MD, PhD | June 9, 2010

 

Andrew J. Armstrong, MD, ScM 
Samuel Silver, MD, PhD

Stay tuned on this page for our upcoming coverage of the American Society of Clinical Oncology meeting 2010 focusing of hematologic malignancies. To deliver the most insightful coverage, we have engaged nationally recognized hematology specialist, Samuel Silver, MD, PhD, Professor, Internal Medicine/Hematology-Oncology and Director of the University Cancer Center Network, University of Michigan Cancer Center, Ann Arbor, Michigan.

First up: An exclusive podcast interview—Dr. Silver elucidates the current trends and therapies for treating various blood cancers.

Next up: An expert perspective, gleaning the best hematologic highlights from this year’s meeting―Dr. Silver's clinical and research expertise spans bone marrow transplantation, malignant hematology, bleeding disorders, platelet dysfunction, myeloproliferative and myelodysplastic disorders and porphyria.

 

Novel Targets, Enhanced Donor Transplantation, Show Promise in Blood Cancers

iTunes Click to download

Watch this page for Dr. Silver's assessment of key sessions, abstracts, current therapies and future trends presented at the American Society of Clinical Oncology meeting 2010.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
MORE PODCASTS

ASCO: Treating Lung Cancer After Targeted Therapy–Resistance
June 11, 2013
ASCO: Preview of the Prostate Cancer Sessions
May 30, 2013
ASCO: Neoadjuvant Therapy Options and Clinical Trials in Breast Cancer
May 29, 2013
Breast Cancer Screening, Risk, and Options for High-Risk Women
May 22, 2013
Colorectal Cancer Treatments and Therapy Innovations
May 22, 2013
 
Topic Index

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
Most Popular
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
Comments
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy